Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Przemyslaw J. Kotyla
Are Janus Kinase Inhibitors Superior Over Classic Biologic Agents in RA Patients?
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Related publications
Janus Kinase Inhibitors for Autoimmune Disorders
Prescriber
Pharmacology
SAT0177 Real-World Interruptions in Janus Kinase Inhibitor Therapy Observed Among Biologic-naÏve and Biologic-Experienced Rheumatoid Arthritis Patients
Development of Selective Covalent Janus Kinase 3 Inhibitors
Journal of Medicinal Chemistry
Drug Discovery
Molecular Medicine
Role of Janus Kinase Inhibitors in the Treatment of Alopecia Areata
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Persistence Rate With Subcutaneous Biologic Therapies in Patients With Rheumatoid Arthritis (Ra)
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Janus Kinase Inhibitors and Allogeneic Stem Cell Transplantation for Myelofibrosis
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Janus Kinase V617F Mutation Detection in Patients With Myelofibrosis
Balkan Journal of Medical Genetics
Genetics
Therapeutic Potential of Janus-Activated Kinase-2 Inhibitors for the Management of Myelofibrosis
Clinical Cancer Research
Cancer Research
Oncology
Biologic Monotherapy in the Biologic Naïve Patient With Rheumatoid Arthritis (RA): Results From an Observational Study
Rheumatology International
Rheumatology
Allergy
Immunology